Follow The Filings

EMN Eastman Chemical Co.

Materials, filed as EASTMAN CHEM CO (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $27K

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.01%

Who owns EMN

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.01% Hold 410 $27K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by EMN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EMN insider trades
  • None no insider bought on the open market
  • $366K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Adrian James Holt SVP, Chf HR Ofcr
    Sale
    $234K 3,283 shares at $71.31 100% of stake
    Traded Aug 4 Filed Aug 6
    ↗
  2. Adrian James Holt SVP, Chf HR Ofcr
    Sale
    $132K 1,709 shares at $77.05 100% of stake
    Traded May 5 Filed May 7
    ↗

Also filed in the last 12 months, not counted as buying or selling: 16 stock grants, 12 share withholdings for taxes, 3 gifts, and 2 option exercises.

Congress

2 members of Congress traded EMN in the last three years: 1 buy and 2 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Aug 4, 2025 filed Sep 12, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  3. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K May 15, 2025 filed Jun 9, 2025

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.03,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated about 4 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $9.21B $9.38B $8.75B
Gross profit $2.06B $2.29B $1.84B
Gross margin * 22.4% 24.4% 21.1%
Net income $894M $905M $474M
Net margin * 9.7% 9.6% 5.4%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $3.48B $4.1B $3.64B
Total non-current assets * $11.15B $11.11B $11.21B
Total assets $14.63B $15.21B $14.86B
Total current liabilities $2.58B $2.71B $2.65B
Total non-current liabilities * $6.53B $6.65B $6.17B
Total equity $5.46B $5.78B $5.96B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.37B $1.29B $0.97B
Cash from investing -$432M -$534M -$462M
Cash from financing -$888M -$454M -$797M
Net change in cash $55M $289M -$271M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.